Evaluation of antimicrobial utilization for dirrheal diseases treatment among under five patients

Registration ID: IJNRD_221661

Published ID: IJNRD2406219

: Click Here to Get

Beyene tola sheri, Assebe Zemdkun, Balkew Yimeru, Tigist Girma, Ayenachew Bayu

Antimicrobial use for diarrheal diseases among under five patients.

Executive Summary Introduction: Diarrhea is defined as passage of 3 or more unusually loose stool or watery stool of any frequency within 24 hours and became second cause of death in under-5-year children globally. Antimicrobial agents are among the most used therapeutics and widely misused of all drugs. These irrational and uncontrollable uses of antibiotics will increases resistance, potential adverse effects and cost. Objective: This study was aimed to evaluate antimicrobial utilization for diarrheal diseases among under-5 out-patients based on IMNCI criteria at Semen health center in Arada sub city of Addis Ababa the capital city of Ethiopia in 2023. Methods: An institutional-based retrospective descriptive cross-sectional study was employed using medication records of under-5 out-patients who treated for diarrheal diseases in 2023 at Semen health center from January 1, 2023 to December 30, 2023. A total of 75 diarrheal diseases treatment records were investigated. Systematic random samplings were employed to collect the required sample from the sampling frame. The collected data was entered into excel statistical data analyzer and computed using descriptive analysis. Descriptive statistics and cross tabulation was carried out, and the result was presented using texts, tables, and graphs. Results: From the total 75 diarrheal diseases treated the overall indications (n=71, 94.67%), dose, strength, frequency band duration (n=67, 89.33%) each and both drug-drug interaction and contra-indication (n=75,100%) were correctly prescribed. Conclusion: This study revealed that antimicrobial use for diarrheal diseases treatment was slightly deviated from criteria and threshold while other medication for diarrheal treatment such as ORS and metoclopramide more deviated from the criteria.

Published Paper   E-Certificate

Beyene tola sheri, Assebe Zemdkun, Balkew Yimeru, Tigist Girma, & Ayenachew Bayu (June-2024). Evaluation of antimicrobial utilization for dirrheal diseases treatment among under five patients. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 9(6), c204-c214. https://ijnrd.org/papers/IJNRD2406219.pdf

Volume 9 Issue 6, June-2024

Pages : c204-c214

Paper Reg. ID: IJNRD_221661

Published Paper Id: IJNRD2406219

Downloads: 000122254

Research Area: Pharmacy

Author Type: Foreign Author

Country: Addis Ababa, Addis ababa, Ethiopia

Published Paper PDF: https://ijnrd.org/papers/IJNRD2406219.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2406219

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition.

You are free to share, adapt, and redistribute the material, provided proper credit is given to the original author. 🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.

Call For Paper - Volume 10 | Issue 12 | December 2025

IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the UGC CARE 2025 Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.

IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.

Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.

How to submit the paper?

By Our website

Click Here to Submit Paper Online

By Mail

Send your paper to editor@ijnrd.org

You can now publish your research in IJNRD. IJNRD is a Transparent Peer-Reviewed Open Access Journal Publication (Refereed Journal), aligning with New UGC and UGC CARE recommendations.

For more details, refer to the official notice: UGC Public Notice

Submit Paper Online

Important Dates for Current issue

Paper Submission Open For: December 2025

Current Issue: Volume 10 | Issue 12 | December 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-Dec-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details

Approval, Licenses and Indexing: More Details